Elevance Health, Inc.
ELV
$404.58
-$7.80-1.89%
NYSE
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 4.81% | 1.06% | 1.45% | 1.51% | 4.91% |
| Total Other Revenue | 16.31% | 14.75% | 12.92% | 15.90% | 18.85% |
| Total Revenue | 6.63% | 3.19% | 3.20% | 3.62% | 6.89% |
| Cost of Revenue | 6.64% | 2.60% | 1.79% | 0.86% | 4.10% |
| Gross Profit | 6.58% | 4.75% | 7.00% | 11.33% | 14.89% |
| SG&A Expenses | 11.92% | 8.91% | 4.66% | 11.49% | 15.49% |
| Depreciation & Amortization | -19.19% | -34.46% | -32.57% | -23.81% | -12.26% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 7.72% | 3.82% | 2.24% | 2.99% | 6.39% |
| Operating Income | -10.65% | -7.00% | 20.59% | 14.28% | 15.42% |
| Income Before Tax | -3.40% | 2.45% | 6.96% | 4.23% | 1.54% |
| Income Tax Expenses | 3.17% | 12.12% | 10.92% | 0.11% | -0.06% |
| Earnings from Continuing Operations | -5.29% | -0.33% | 5.83% | 5.46% | 2.01% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 37.50% | 325.00% | 170.73% | 140.00% | 142.11% |
| Net Income | -5.24% | -0.12% | 7.04% | 6.04% | 2.46% |
| EBIT | -10.65% | -7.00% | 20.59% | 14.28% | 15.42% |
| EBITDA | -10.71% | -8.97% | 13.56% | 9.19% | 11.29% |
| EPS Basic | -3.19% | 1.73% | 9.12% | 8.27% | 4.47% |
| Normalized Basic EPS | -12.32% | -7.67% | 25.81% | 17.68% | 18.25% |
| EPS Diluted | -3.14% | 1.74% | 9.17% | 8.46% | 4.85% |
| Normalized Diluted EPS | -12.32% | -7.71% | 25.96% | 17.99% | 18.80% |
| Average Basic Shares Outstanding | -2.02% | -1.85% | -1.91% | -2.00% | -1.93% |
| Average Diluted Shares Outstanding | -2.07% | -1.90% | -1.96% | -2.19% | -2.30% |
| Dividend Per Share | 8.73% | 10.14% | 11.36% | 12.68% | 14.10% |
| Payout Ratio | 0.12% | 0.08% | 0.02% | 0.04% | 0.09% |